ALPS Advisors »

Celldex Therapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 38k 39.66
2023-09-30 $959k 35k 27.52
2023-06-30 $1.2M 35k 33.93
2023-03-31 $1.1M 31k 35.98
2022-12-31 $1.4M 32k 44.57
2022-09-30 $718k 26k 28.09
2022-06-30 $748k 28k 26.96
2021-03-31 $1.5M 72k 20.61
2020-12-31 $1.2M 71k 17.52